Related Experiment Video

Updated: Apr 26, 2026

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment
11:13

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment

Published on: June 9, 2023

2.3K

p90/CIP2A mediates breast cancer cell proliferation and apoptosis

Xinxin Liu1, Bo Peng, Yang Li

  • 1Department of Biology Sciences, The University of Texas at El Paso, El Paso, TX, 79968, USA.

Molecular Biology Reports
|August 4, 2014
PubMed

Insights

Cancerous inhibitor of PP2A (CIP2A) drives breast cancer growth by promoting cell proliferation. Inhibiting CIP2A reduces tumor growth and increases apoptosis, suggesting it as a potential therapeutic target.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Cancerous inhibitor of PP2A (CIP2A) is an oncoprotein overexpressed in human malignancies.
  • CIP2A inhibits PP2A phosphatase activity, promoting cell proliferation and tumor growth.
  • The precise role of CIP2A in cancer progression remains incompletely understood.

Purpose of the Study:

  • To investigate the biological function of CIP2A in breast cancer progression.
  • To evaluate CIP2A's role in cell proliferation and apoptosis in breast cancer cells.
  • To explore CIP2A as a potential therapeutic target for breast cancer treatment.

Main Methods:

  • Utilized shRNA knockdown in MDA-MB-231 and LM2-4 breast cancer cell lines.
  • Performed cell proliferation assays, colony formation assays, and flow cytometry.
  • Analyzed the expression of c-Myc and p-ERK1/2 following CIP2A depletion.

Main Results:

  • CIP2A depletion significantly inhibited proliferation in breast cancer cells.
  • Silencing CIP2A increased paclitaxel-induced apoptosis.
  • Down-regulation of c-Myc and p-ERK1/2 levels was observed upon CIP2A silencing.

Conclusions:

  • CIP2A acts as a crucial oncoprotein involved in breast cancer cell proliferation and apoptosis.
  • Targeting CIP2A may represent a viable therapeutic strategy for breast cancer treatment.

More Related Videos

Utilization of the Soft Agar Colony Formation Assay to Identify Inhibitors of Tumorigenicity in Breast Cancer Cells11:06

Utilization of the Soft Agar Colony Formation Assay to Identify Inhibitors of Tumorigenicity in Breast Cancer Cells

Published on: May 20, 2015

28.8K
Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen19:44

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen

Published on: May 30, 2012

18.2K

Related Concept Videos

The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.2K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

4.3K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.0K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
32.1K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
4.6K